1

2

3

4

5

6

7

8

9

10

11

12

13

CDER Nonprescription & Enocrinologic-Metabolic (Joint Meeting)

CDRH Circulatory System Devices

14

CDER Nonprescription & Enocrinologic-Metabolic (Joint Meeting)

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

CVM Veterinary Medicine

1

2

3

4

5

6

7

8

CBER Transmissible Spongiform Encephalopathies

9

10

11

12

13

14

FDA Pediatrics

15

FDA Pediatrics

16

CDER Joint Meeting Arthritis & Drug Safety and Risk Management

CBER Vaccines & Related Products

17

CDER Joint Meeting Arthritis & Drug Safety and Risk Management

CBER Vaccines & Related Products

18

CDER Joint Meeting Arthritis & Drug Safety and Risk Management

19

20

21

22

23

24

CDER Cardiovascular & Renal Drugs

25

26

27

28

1

2

3

CBER Cellular,Tissue, & Gene Therapies (Notice Amended)

CDER Oncologics

4

CBER Cellular,Tissue, & Gene Therapies (Notice Amended)

CDER Oncologics

5

6

7

8

9

10

11

CDER Antiviral Drugs

12

13

14

15

CBER Vaccines & Related Products

16

17

CBER Blood Products

CDRH Circulatory System Devices

18

CBER Blood Products

19

20

21

22

23

CDER Nonprescription Drugs

24

CDER Joint Meeting Dermatologic-Ophthalmic Drugs and Nonprescription Drugs

25

26

27

28

29

30

31

1

2

3

4

5

CDER Cardiovascular & Renal Drugs
Meeting Canceled

6

7

CBERAllergenic Products

8

9

10

11

CDRH General & Plastic Surgery

12

CDRH General & Plastic Surgery

13

CDRH General & Plastic Surgery

14

15

FDA Science Board

16

17

18

19

20

21

22

CDRH Circulatory Systems Devices

23

24

25

26

27

28

29

30

1

2

3

CDER Pharmaceutical Science

4

CDER Pharmaceutical Science

5

CDER Oncologic Drugs

6

7

8

9

10

11

12

13

CDRH Anesthesiology & Respiratory Therapy

14

15

16

17

CDRH Obstetrics & Gynecology Devices

18

CDER Drug Safety & Risk Management - Change in Meeting Start Time

19

CDER Drug Safety & Risk Management - Change in Meeting Start Time

CDER Antiviral Drugs

20

CBER Cellular, Tissue, & Gene Therapies

21

22

23

24

25

26

27

28

29

30

31

1

2

3

4

5

6

CDER Pulmonary-Allergy Drugs

7

8

CDRH Gastroenterology-Urology

9

10

NCTR Ranch Hands

11

12

13

14

15

CDER Cardiovascular & Renal Drugs

16

CDER Cardiovascular & Renal Drugs

17

CDRH Neurological Devices

18

19

20

21

22

CDRH Circulatory System Devices

23

CDRH Circulatory System Devices

CDRH Obstetrics & Gynecology Devices

24

25

26

27

28

FDA Pediatric Ethics Subcommittee of the Pediatric Advisory Committee

29

FDA Pediatric Advisory Committee

30

FDA Pediatric Advisory Committee

1

2

3

4

5

6

7

8

9

10

11

12

13

CDER Pulmonary-Allergy Drugs

CFSAN Food Advisory Committee

14

CDER Pulmonary-Allergy Drugs

CFSAN Food Advisory Committee

15

CDRH Immunology Devices Panel

CFSAN Food Advisory Committee

16

17

18

19

20

21

CBER Blood Products

22

CBER Research Review Subcommittee of Blood Products

23

24

25

26

27

28

29

CBER Cellular, Tissue, and GeneTherapies

30

31

1

2

3

4

CDER Peripheral & Central Nervous System

5

6

7

8

9

CDRHGeneral Hospital and Personal Use Devices

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

CDRH General & Plastic Surgery Devices

26

CDRH General & Plastic Surgery Devices

27

28

29

30

31

1

2

3

4

5

6

CDER Arthritis

7

8

CDER Endocrinologic & Metabolic Drugs

CDRH Orthopaedic and Reahabilitation Devices

9

CDER Endocrinologic & Metabolic Drugs

CDRH Orthopaedic and Reahabilitation Devices

10

11

12

13

CDER Oncologic Drugs

14

CDER Oncologic Drugs

15

16

17

18

19

20

21

22

CBER Vaccines & Related Biological Products

23

24

25

26

CDRH National Mammography Quality Assurance

27

CDRH National Mammography Quality Assurance

CDRH General Hospital & Personal Use

28

29

CBER Cellular, Tissue & Gene Therapies

CBER Blood Products

30

1

2

3

4

5

6

7

8

9

10

11

CDRH Dental Products Panel

12

CDRH Dental Products Panel

13

14

15

16

17

18

19

20

CDER Nonprescription Drugs

CDER Pediatric Subcommittee of Oncologic Drugs

21

CDER Nonprescription Drugs

22

23

24

25

CDER Psychopharmacologic Drugs

CDER Pharmaceutical Science

26

CDER Psychopharmacologic Drugs

CDER Pharmaceutical Science

27

28

29

30

31

CBER Transmissible Spongiform Encephalopathies

1

2

3

CBER Blood Products

4

CBER Blood Products

FDA Science Board to the FDA

5

6

7

8

CDER Oncologic Drugs - Notice Amended: Change in Agenda

9

10

CDER Anesthetic & Life Support Drugs

11

12

13

14

CDER Pharmaceutical Science - Clinical Pharmacology

15

FDA Pediatric Ethics Subcommittee

CDER Pharmaceutical Science - Clinical Pharmacology

16

FDA Pediatric Advisory Committee

CBER Vaccines and Related Bilogical Products

CDER Cardiovascular and Renal Drugs

17

FDA Pediatric Advisory Committee

CBER Vaccines and Related Bilogical Products

18

FDA Pediatric Advisory Committee

NCTR Ranch Hands

19

20

21

22

23

24

25

26

27

28

29

30

1

2

CDER Psychopharmacologic Drugs

3

4

5

6

7

8

9

10

11

12

13

14

CBER Vaccines & Related Biological Products

15

CBER Vaccines & Related Biological Products

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31